| A&P LIFESCIENCE FUND, FI A | BIOTECNOLOGÍA | 43,42% | 32,26% | · | · |
| NATIXIS ASIA EQUITY R/A (USD) | RVI ASIA EX-JAPÓN | 43,42% | 38,65% | 3,10% | 74,07% |
| CHALLENGE ENERGY EQUITY EVOLUTION L-A | ENERGÍA | 43,41% | 39,48% | 109,18% | 74,48% |
| ISHARES NASDAQ US BIOTECHNOLOGY UCITS ETF USD (ACC) | BIOTECNOLOGÍA | 43,40% | 33,94% | 31,44% | · |
| INVESCO GREATER CHINA EQUITY A DIS ANNUAL EUR | RVI CHINA | 43,39% | 30,71% | -10,62% | 79,10% |
| SCHRODER ISF JAPANESE OPPORTUNITIES C DIS JPY | RVI JAPÓN VALOR | 43,39% | 51,90% | 37,36% | 86,48% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES EU1D | RVI EUROPA | 43,37% | 85,07% | 137,69% | 214,76% |
| AMUNDI STOXX EUROPE SELECT DIVIDEND 30 UCITS ETF DIST | RVI EUROPA | 43,36% | 50,12% | 30,12% | 46,52% |
| MAPFRE AM - IBERIAN EQUITIES R EUR CAP | RV ESPAÑA | 43,36% | 71,74% | 78,12% | · |
| SCHRODER ISF GLOBAL RECOVERY I ACC USD | RVI GLOBAL VALOR | 43,36% | 53,91% | 81,32% | 194,38% |
| BGF ASIAN DRAGON D2 GBP | RVI ASIA EX-JAPÓN | 43,35% | 35,05% | 18,41% | 121,19% |
| LO FUNDS - TRANSITION MATERIALS SYST. NAV HDG (EUR) R CAP | MATERIAS PRIMAS | 43,35% | 28,88% | 65,58% | 62,31% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES US1 | RVI EUROPA | 43,34% | 84,99% | 137,76% | 209,90% |
| ALKEN FUND - EUROPEAN OPPORTUNITIES EU1 | RVI EUROPA | 43,33% | 85,01% | 137,63% | 214,77% |
| ABRDN SICAV I-JAPANESE SMALLER COMPANIES SUSTAINABLE EQUITY FUND A ACC JPY | RVI JAPÓN SMALL/MID CAP | 43,32% | 37,69% | 5,15% | 70,88% |
| HSBC GIF ASIA EX JAPAN EQUITY SMALLER COMPANIES EC USD | RVI ASIA EX-JAPÓN | 43,32% | 42,59% | 19,58% | 89,15% |
| AB FCP I-EMERGING MARKETS GROWTH PORTFOLIO B USD | RVI EMERGENTES | 43,29% | 40,94% | 10,88% | 78,44% |
| PICTET - ASIAN EQUITIES EX JAPAN HR EUR | RVI ASIA EX-JAPÓN | 43,29% | 35,33% | -17,12% | 60,74% |
| UBS MSCI CANADA UCITS ETF HGBP ACC | RVI USA | 43,29% | 83,71% | 97,24% | · |
| BGF ASIAN DRAGON D2 EUR | RVI ASIA EX-JAPÓN | 43,28% | 35,40% | 18,25% | 121,39% |
